OpenLegislation

Division 1.2.5 Inactivation or removal of TSE infectious agents

United Kingdom

Original text. Later amendments are not shown.

  1. 1.2.5.1Division 1.2.5.1
  2. 1.2.5.2For other devices, if claims are made by the manufacturer for the ability of manufacturing processes to remove or inactivate TSE infectious agents, these must be substantiated by appropriate documentation.

Notes on Division 1.2

Textual amendments

F1

Words in Annex 1 s. 1.2 substituted (11.8.2021) by The Medical Devices (Amendment) (EU Exit) Regulations 2021 (S.I. 2021/873), reg. 1(1), Sch. 2 para. 15(a)